In a recent interview with Forbes Magazine, Vivek Dhawan, CEO and Chief Coach, revealed that “Mega Lifesciences has grown from being the first soft-gel manufacturer in Thailand in 1986 to become a leading global company today. Mega Lifesciences started with 2 machines and 10 people, but now we have over 4,000 employees, and manufacturing plants in Thailand and Australia, with 367.7 million baht in paid up capital. We will enter the Stock Exchange of Thailand, offering 216.31 million shares, by the end of this year. In 2012, Mega Lifesciences had total revenue of 5.96 billion baht, of which approximately 30% came from Myanmar, 25% came from Vietnam and 19% came from Thailand.”

“Mega Lifesciences now has 627 active product registrations under the ‘Mega We Care’ brand, which is sold in Thailand, Vietnam, Myanmar, Cambodia, Russia and 24 other countries, predominantly in Africa and Asia. Mega Lifesciences PCL is also focused on the distribution of pharmaceuticals and consumer goods in Thailand’s neighboring countries, under the ‘Maxxcare’ business. Today, Maxxcare has eight warehouses in six cities across Myanmar and has become the leading nutritional supplements and pharmaceuticals distributor covering many thousands of stores, with key partners including Pfizer, GlaxoSmithKline, Novartis, Nestle, Schick and Osotspa. In Vietnam, Mega Lifesciences has 600 staff and 3 warehouses in Hanoi, Ho Chi Minh City and Danang. Across Asia, we distribute Mega We Care products, covering 12,000 stores across India and Indonesia, for example. In Thailand, Mega Lifesciences started by acquiring Medicraft, and also established the Health Food and Supplements Association to help the Food and Drug Administration of Thailand develop regulations covering nutritional supplements,” Vivek concluded.